← FDA Drug Approvals (Drugs@FDA)
RISPERDAL
NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2003-04-02
Drug application
- FDA Application #
NDA021444- Application type
- New Drug Application
- Brand name
- RISPERDAL
- Generic name
- RISPERIDONE
- Active ingredients
- RISPERIDONE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- JANSSEN PHARMS
- Manufacturer
- Janssen Pharmaceuticals, Inc.
- First approval
- 2003-04-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown